Neovate Capital Partners
Overview
Neovate Capital Partners is a venture capital firm that invests in early-stage life sciences companies, focusing on transformational medical devices and category-defining therapeutics at critical pre-inflection points.
Portfolio Companies
3
Website
neovate.vcInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| TYBR Health | Jul 2026 | Series A | Co-investor |
| OSSTEC | Nov 2026 | VC Round | Co-investor |
| Icarus Medical | Jun 2026 | Series A | Co-investor |
Key People
Kevin Rocco
Partner
Matt Harbaugh
Partner
Nick Pachuda
Chief Operating Officer
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Neovate Capital Partners based?
Neovate Capital Partners is headquartered in Pittsburgh, Pennsylvania, United States.
When was Neovate Capital Partners founded?
Founding year information for Neovate Capital Partners is not publicly available.
How many portfolio companies does Neovate Capital Partners have?
Neovate Capital Partners has 3 portfolio companies in Caplight's dataset.
What are some companies in Neovate Capital Partners's portfolio?
Portfolio companies visible on Caplight include TYBR Health, OSSTEC, Icarus Medical.
What was Neovate Capital Partners's most recent investment shown here?
Neovate Capital Partners's most recent investment in this portfolio sample was in OSSTEC in 2026.
What sectors does Neovate Capital Partners focus on?
Neovate Capital Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Neovate Capital Partners focus on?
Neovate Capital Partners typically invests at the Early stage.